Compare Acotec Scientific Holdings Ltd. with Similar Stocks
Dashboard
1
Weak Long Term Fundamental Strength with a 72.76% CAGR growth in Operating Profits over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0.34
- The company has been able to generate a Return on Equity (avg) of 2.70% signifying low profitability per unit of shareholders funds
2
Flat results in Dec 25
3
With ROE of -0.90%, it has a Very Expensive valuation with a 2.34 Price to Book Value
Stock DNA
Pharmaceuticals & Biotechnology
HKD 2,999 Million ()
NA (Loss Making)
NA
0.00%
-0.58
-0.87%
1.82
Revenue and Profits:
Net Sales:
104 Million
(Quarterly Results - Jun 2021)
Net Profit:
33 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
49.3%
0%
49.3%
6 Months
39.5%
0%
39.5%
1 Year
26.75%
0%
26.75%
2 Years
-35.69%
0%
-35.69%
3 Years
45.88%
0%
45.88%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Acotec Scientific Holdings Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
15.99%
EBIT Growth (5y)
72.76%
EBIT to Interest (avg)
0.34
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.62
Sales to Capital Employed (avg)
0.46
Tax Ratio
0.61%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
4.38%
ROE (avg)
2.70%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.34
EV to EBIT
293.03
EV to EBITDA
182.47
EV to Capital Employed
4.71
EV to Sales
15.99
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
1.61%
ROE (Latest)
-0.90%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
699.10
579.00
20.74%
Operating Profit (PBDIT) excl Other Income
145.30
85.50
69.94%
Interest
11.10
12.50
-11.20%
Exceptional Items
17.20
3.20
437.50%
Consolidate Net Profit
129.30
56.70
128.04%
Operating Profit Margin (Excl OI)
124.60%
53.10%
7.15%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 20.74% vs 10.58% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 128.04% vs 254.38% in Dec 2024
About Acotec Scientific Holdings Ltd. 
Acotec Scientific Holdings Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






